A recent study reported that treatment of experimental autoimmune encephalomyelitis (EAE) mice with the eukaryotic plasmid DT390-IL-18-Sra (encoding recombinant immunotoxin DT390-IL-18) suppressed clinical and histopathological progression of disease [16]. The gene discussed is IL18; the disease is experimental autoimmune encephalomyelitis.